Bayer, stuck in one of the worst crises in its 155-year history, is worth less today than the $63 billion it paid for Monsanto
Bayer’s market capitalization has plunged amid investor worries about its potential liabilities related to weedkiller Roundup. Above, a farmer sprays Roundup. Photo: jean-francois monier/Agence France-Presse/Getty Images By Ruth Bender Updated May 19, 2019 6:11 p.m. ET BERLIN—Less than a year after Bayer AG acquired Monsanto Co. and its Roundup weedkiller, the German company is stuck at what could be one of its darkest hours.
Bayer is appealing the verdicts and argues that hundreds of studies and regulatory bodies around the world including the U.S. Environmental Protection Agency have concluded that Roundup and its active ingredient, glyphosate, are safe. Markus Manns, a fund manager with Union Investment, a major Bayer shareholder, said, “With every new verdict, people are less confident that Bayer will get away with a settlement below €5 billion”—about $5.58 billion.
That is partly because shareholders including DWS, Deutsche Bank AG’s asset-management branch, said a management reshuffle would only deepen the crisis. Moreover, many investors believe that any such change would likely have to include Bayer Chairman Werner Wenning, a mentor to Mr. Baumann and another driving force behind the Monsanto deal. Investors also are divided over whether the acquisition will ever pay off for Bayer.
Most analysts and shareholders agree with Bayer that it would be unwise to settle before some appeals have been heard. Company attorneys told reporters Wednesday that Bayer would participate “in good faith” in mediation ordered by a judge overseeing hundreds of Roundup cases but that the outcomes of appeals are critical before any possible settlement.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
California jury says Bayer must pay $2 billion to couple in Roundup cancer trialJUST IN: California jury awards more than $2 billion to couple who claimed Bayer's glyphosate-based Roundup weed killer caused their cancer by TinaBellon
Lire la suite »
In Latest Roundup Herbicide Defeat for Bayer, Jury Awards California Couple $2 BillionBayer faced its third courtroom defeat from a lawsuit alleging Roundup weedkiller led to cancer, with a California jury awarding a couple $2.055 billion in damages.
Lire la suite »
Bayer to pay $2 billion after losing suit that claims weedkiller Roundup causes cancerBayer AG on Monday was ordered by a California jury to pay $2 billion to a couple who say they were diagnosed with cancer after using the company's weedkiller Roundup.
Lire la suite »
California jury awards couple $2 billion in latest Roundup herbicide defeat for BayerA jury dealt Bayer AG a third court defeat, awarding $2.055 billion to a California couple who blamed the German company’s Roundup weedkiller for causing...
Lire la suite »
California jury hits Bayer with $2 billion award in Roundup cancer trialA California jury on Monday awarded more than $2 billion to a couple who claimed...
Lire la suite »
Bayer stock at lowest in nearly seven years after $2 billion award in Roundup trialShares in Bayer were down 5.9 percent in early trade on Tuesday after a jury awa...
Lire la suite »
Bayer stock continues rout after $2 billion award in Roundup trialShares in Bayer fell as much as 5 percent on Tuesday after a jury awarded more t...
Lire la suite »
Bayer Shares Fall After $2 Billion Roundup VerdictBayer shares resumed their monthslong fall after the company was hit by a more-than $2 billion jury award over its Roundup herbicide, marking a sharp escalation in the chemical and drug giant’s legal woes.
Lire la suite »
Bayer nears seven-year low after $2 billion award in Roundup trialBayer nears seven-year low after California couple awarded $2 billion in Roundup trial via LudwigBurger
Lire la suite »
Factbox: More Roundup trials, appeals in store for Bayer after $2 billion verdictBayer shares continued to fall on Tuesday after a California jury on Monday awar...
Lire la suite »
Bayer bets on 'silver bullet' defense in Roundup litigation; experts see hurdlesBayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsu...
Lire la suite »